摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-苯并呋喃-2,3-二醇 | 163463-62-5

中文名称
1-苯并呋喃-2,3-二醇
中文别名
——
英文名称
1-Benzofuran-2,3-diol
英文别名
——
1-苯并呋喃-2,3-二醇化学式
CAS
163463-62-5
化学式
C8H6O3
mdl
——
分子量
150.13
InChiKey
DNDWXJDUTDZBNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    310.3±22.0 °C(Predicted)
  • 密度:
    1.454±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    53.6
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES
    申请人:Martineau Louis C.
    公开号:US20140135359A1
    公开(公告)日:2014-05-15
    The present invention provides a computer-assisted method of generating a protonophore requiring the use of a computer including a processor. The method includes: designing the protonophore, calculating, using the processor, an estimated protonophoric activity; producing the protonophore if the estimated protonophoric activity corresponds to an U 50 of about 20 μM or less; and determining the uncoupling activity of the protonophore. The present invention also provides novel protonophores that meet the above requirement and their methods of use.
    本发明提供了一种利用计算机辅助的方法来生成需要使用处理器的质子载体。该方法包括:设计质子载体,使用处理器计算估计的质子载体活性;如果估计的质子载体活性对应于大约20微米或更少的U50,则生产质子载体;并确定质子载体的解耦活性。本发明还提供了符合上述要求的新型质子载体及其使用方法。
  • INHIBITORS OF SERINE PROTEASES
    申请人:Cottrell Kevin M.
    公开号:US20110182856A1
    公开(公告)日:2011-07-28
    The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.
    本发明涉及式(I)化合物或其药学上可接受的盐。这些化合物抑制丝氨酸蛋白酶,特别是丙型肝炎病毒NS3-NS4A蛋白酶
  • Process for preparing substituted 2,3-dihydrobenzofuran
    申请人:ENICHIMICA SECONDARIA S.p.A.
    公开号:EP0127208A1
    公开(公告)日:1984-12-05
    Preparation of substituted 2,3-dihydrobenzofuran which can be defined by the general formula: wherein; Ra is hydrogen, halogen, or an alkyl radical, straight lined or branched containing from 1 to 4 carbon atoms, aryl, alkaryl, -OH, -OR3, -N(Ra)2, (Rabeing, in its turn, an alkyl' radical, straight lined or branched containing from 1 to 4 carbon atoms); Rb is an alkyl radical, straight lined or branched containing from 1 to 6 carbon atoms, aryl or alkaryl; Rc is hydrogen or has the same meaning as Rb; by rearrangement of 1,1-bis(2-hydroxybenzene)alkyl and/or aryl-ethane, which can be defined by the general formula: wherein Ra, Rb and Rc have the above specified meanings, working in the presence of catalytic amounts of at least a mineral or an organic acidic compound, at a high temperature and withdrawing from the reaction mass the products of the rearrangement reactions they are being formed. The 1,1-bis(2-hydroxybenzene)alkyl and/or arylethane are obtained starting from substituted phenols and aldehydes under the influence of specially provided catalysts. Within the scope of this reaction, 1,1-bis(2,3-dihydroxybenzene)alkyl or aryl-methane are found, which can be defined by the general formula: wherein: R is an alkyl radical, straight lined or branched, containing from 1 to 20 carbon atoms, or an aryl radical; R1, R2 and R3 are equal to or different from each other and represent: H, halogen, or the alkyl radical, straight lined or branched, containing from 1 to 4 carbon atoms, aryl, alkaryl, -OH, -OR4,-N(R4)2, R4 being an alkyl radical, straight lined or branched. containing from 1 to 4 carbon atoms. Such compounds are obtained by reaction of a biphenol which can be defined by the general formula: with an aldehyde which can be defined by the general formula wherein R, R,, R2 and R3 have the meanings specified hereinabove, working in the presanca of catalytic amounts of at least one compound, which is a member selected from the group consisting of oxides, hydroxides, alcoholates and carboxylates of the metals belonging to the IA, IIA, IIB and VIIB of the Periodic System of the Eiements, in the presence, or not, of a liquid and inert (i.e. nonreactive) organic solvent, the water being fowned as a reaction byproduct being optionally withdrawn as it is formed.
    制备取代的2,3-二氢苯并呋喃,其通式定义如下 其中;Ra 是氢、卤素、或含有 1 至 4 个碳原子的直链或支链烷基、芳基、烷芳基、-OH、-OR3、-N(Ra)2,(Rabeing 则是含有 1 至 4 个碳原子的直链或支链烷基); Rb 是含有 1 至 6 个碳原子的直链或支链烷基、芳基或烷芳基; Rc 是氢或与 Rb 具有相同的含义;通过对 1,1-双(2-羟基苯)烷基和/或芳基乙烷进行重排,可按通式定义: 其中 Ra、Rb 和 Rc 具有上述特定含义,在催化量至少为矿物或有机酸化合物存在下,在高 温下进行,并从反应物团中抽出正在形成的重排反应产物。 在专门提供的催化剂作用下,可以从取代的苯酚和醛中获得 1,1-双(2-羟基苯)烷基和/或芳基乙烷。 在该反应的范围内,可以发现 1,1-双(2,3-二羟基苯)烷基或芳基甲烷,它们可以用通式来定义: 其中R 是含有 1 至 20 个碳原子的直链或支链烷基或芳基; R1、R2 和 R3 相等或互不相同,并代表:H、卤素或含有 1 至 4 个碳原子的直链或支链烷基、芳基、烷芳基、-OH、-OR4、-N(R4)2,其中 R4 为含有 1 至 4 个碳原子的直链或支链烷基。 此类化合物是由通式中定义的双与醛反应得到的: 与醛反应而得,醛的定义见通式 其中 R、R、R2 和 R3 的含义如上文所述,在催化剂的作用下,在液体和惰性(即非 反应性)有机溶剂存在或不存在的情况下,至少使用一种化合物,该化合物选自由元素周期 系 IA、IIA、IIB 和 VIIB 属的氧化物、氢氧化物、醇酸盐和羧酸盐组成的组。在有或没有液体和惰性(即非反应性)有机溶剂存在的情况下,生成的作为反应副产物被抽出。
  • Pharmaceutical oxan preparation
    申请人:——
    公开号:US20040022834A1
    公开(公告)日:2004-02-05
    The invention concerns a topical pharmaceutical preparation, characterized in that it consists of the combination of an oxan and a pharmaceutically acceptable excipient for transdermal delivery of said oxan.
    本发明涉及一种外用药物制剂,其特征在于它由一种氧杂蒽和一种药学上可接受的赋形剂组合而成,用于透皮给药所述氧杂蒽
  • A METHOD OF CHARACTERIZING PHYTOCHEMICALS FROM TRIGONELLA FOENUM GRACEUM
    申请人:Avesthagen Limited
    公开号:EP2417446A1
    公开(公告)日:2012-02-15
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 顺式-1-((2-(5-氯-2-苯并呋喃基)-4-甲基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 顺式-1-((2-(5,7-二氯-2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-咪唑 顺式-1-((2-(2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 霉酚酸酯杂质B 雷美替胺杂质3 雷美替胺杂质22 雷美替胺杂质 间甲酚紫 间甲基苯基(苯并呋喃-2-基)甲醇 长管假茉莉素C 钠1,4-二[(2-乙基己基)氧基]-1,4-二氧代-2-丁烷磺酸酯-3,3-二(4-羟基苯基)-2-苯并呋喃-1(3H)-酮(1:1:1) 金霉素 酪氨酸,b-羰基- 酞酸酐-d4 酚酞二丁酸酯 酚酞 酚红钠 酚红 邻苯二甲酸酐与马来酸酐,甘氨酰蜡素和二乙二醇的聚合物 邻苯二甲酸酐与己二醇的聚合物 邻苯二甲酸酐与三甘醇异壬醇的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇和2,5-呋喃二酮的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇、2,5-呋喃二酮和2-乙基己酸苯甲酸酯的聚合物 邻苯二甲酸酐-13C6 邻苯二甲酸酐-4-硼酸频哪醇酯 邻苯二甲酸酐,马来酸,二乙二醇,新戊二醇聚合物 邻甲酚酞二庚酸酯 邻甲酚酞二己酸酯 邻甲酚酞 贝康唑 表灰黄霉素 螺佐呋酮 螺[苯并呋喃-3(2H),4-哌啶] 螺[异苯并呋喃-1(3H),4’-哌啶]-3-酮 螺[异苯并呋喃-1(3H),4'-哌啶]-3-酮盐酸盐 螺[异苯并呋喃-1(3H),3’-吡咯烷]-3-酮 螺[1-苯并呋喃-2,1'-环丙烷]-3-酮 薄荷内酯 萘并[2,3-b]呋喃-8(4H)-酮,4a,5,6,7,8a,9-六氢-,顺- 莫罗卡尼 荨麻叶泽兰酮 荧光胺 苯酞-3-乙酸 苯酚,2-[3-(2-苯并呋喃基)-5,6-二氢-1,2,4-三唑并[3,4-b][1,3,4]噻二唑-6-基]- 苯酐二乙二醇共聚物 苯酐 苯甲酸,2-[(1,3-二羰基丁基)氨基]-,甲基酯 苯甲酸,2,2-二(羟甲基)丙烷-1,3-二醇,异苯并呋喃-1,3-二酮 苯甲酰氯化,3-甲氧基-4-甲基-